Literature DB >> 17228526

Cancer chronomics II. Origins of timing cancer treatment.

Germaine Cornélissen1, Mikhail Victorovich Berezkin, Elena V Syutkina, Mikhail A Blank, Olga A Blank, Sergei M Chibisov, Franz Halberg.   

Abstract

This paper is a memorial to Mikhail Victorovich Berezkin (MVB) (10 April 1940 - 16 January 2005), an enthusiastic advocate of chrono-oncology. It illustrates his early dose- and circadian time-response curves, limited as yet by a 4-timepoint approach, provides a list of his publications, and offers a succinct overview of individualized marker rhythm-guided oncotherapy.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17228526      PMCID： PMC2662510     

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN： 1359-4117


  25 in total

Review 1.  Toward a chronotherapy of ovarian cancer with taxol. Part II: Test pilot study on circulating CA125.

Authors:  E Halberg; H J Long; G Cornélissen; M A Blank; S Elg; Y Touitou; E Bakken; P Delmore; E Haus; L Sackett-Lundeen
Journal:  Chronobiologia       Date:  1992 Jan-Mar

2.  Toward a chronotherapy of ovarian cancer. Part III: Salivary CA125 for chronochemotherapy by efficacy.

Authors:  G Cornélissen; F Halberg; E Halberg; C Bingham; E Haus; R C Bast; S Fujii; H J Long; F Halberg; K Tamura
Journal:  Chronobiologia       Date:  1992 Jul-Dec

Review 3.  The week in phylogeny and ontogeny: opportunities for oncology.

Authors:  F Halberg
Journal:  In Vivo       Date:  1995 Jul-Aug       Impact factor: 2.155

4.  Power of chronobiologic pilots: a statistician's opinion.

Authors:  D A Berry
Journal:  Chronobiologia       Date:  1993 Jul-Dec

5.  A lady and chronobiology.

Authors:  B J Kennedy
Journal:  Chronobiologia       Date:  1993 Jul-Dec

6.  Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity.

Authors:  F Lévi; M Benavides; C Chevelle; F Le Saunier; F Bailleul; J L Misset; C Regensberg; J M Vannetzel; A Reinberg; G Mathé
Journal:  J Clin Oncol       Date:  1990-04       Impact factor: 44.544

Review 7.  From experimental units to unique experiments: chronobiologic pilots complement large trials.

Authors:  F Halberg; G Cornélissen; C Bingham; S Fujii; E Halberg
Journal:  In Vivo       Date:  1992 Jul-Aug       Impact factor: 2.155

8.  Combined chronochemotherapy of L1210 leukemic mice using 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine, methylprednisolone and cis-diamminedichloroplatinum.

Authors:  L E Scheving; E R Burns; F Halberg; J E Pauly
Journal:  Chronobiologia       Date:  1980 Jan-Mar

9.  Spectral differences between epitopes in the cronomes of salivary CA130 and CA125.

Authors:  A Portela; G Cornélissen; F Halberg; R C Bast; S Fujii; F Xu; Y Yu; M Takagi; J Halberg; F Halberg
Journal:  In Vivo       Date:  1995 Jul-Aug       Impact factor: 2.155

10.  Chronobiologic aspects of urinary gonadotropin peptide (UGP).

Authors:  G Cornélissen; F Halberg; R Walker; R M Zaslavskaya; R L Fine; E Haus
Journal:  In Vivo       Date:  1995 Jul-Aug       Impact factor: 2.155
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.